BMO Capital Markets affirmed their positive stance on Novo Nordisk (NYSE:NVO) shares, maintaining an Outperform rating and a $105.00 price target. This confirmation followed the U.S. Food and Drug ...

Leerink Partners analyst David Risinger noted the significant concern about the likelihood of success of TX45 in PH-HFpEF ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...

Donald Trump continues to make waves in biopharma; Sage rejects Biogen’s unsolicited takeover offer; the obesity space sees ...

$ 87.86-0.11-0.13% ...

Denmark needs to be closer to spending 5 percent of GDP on defense than 2 percent.This was announced by Prime Minister Mette Frederiksen after she concluded her blitz through Europe on Tuesday with a ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Acorda Therapeutics has filed for bankruptcy protection, hoping to keep operating while it tries to arrange the sale of its main assets to a US subsidiary of Germany’s Merz. The announcement ...

Digital health company Akili has launched a non-prescription version of its attention-deficit hyperactivity disorder (ADHD) digital therapeutic EndeavorRx, that can be downloaded from the Apple ...

A few years ago, the Social Democratic government set up a commission for “the forgotten women’s struggle”.On Wednesday, the commission published its recommendations. These are proposals to how Danish ...

Market Domination Overtime hosts Julie Hyman and Josh Lipton detail the top market events on the horizon for the upcoming week. A slew of Big Tech earnings is scheduled for release, with ...